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Abstract
The adipose tissue has important secretory and endocrine functions in humans. The regulation of
adipocyte differentiation has been actively pursued using transcriptomic methods over the last several
years. Quantitative proteomics has emerged as a promising approach to obtain temporal profiles of
biological processes such as differentiation. Stable isotope labeling with amino acids in cell culture
(SILAC) is a simple and robust method for labeling proteins in vivo. Here, we describe the
development and application of a five-plex SILAC experiment using four different heavy stable
isotopic forms of arginine to study the nuclear proteome and the secretome during the course of
adipocyte differentiation. Tandem mass spectrometry analysis using a quadrupole time-of-flight
instrument resulted in identification of a total 882 proteins from these two proteomes. Of these
proteins, 427 were identified on the basis of one or more arginine containing peptides that allowed
quantitation. In addition to previously reported molecules that are differentially expressed during the
process of adipogenesis (e.g. adiponectin and lipoprotein lipase), we identified several proteins whose
differential expression during adipocyte differentiation has not been documented previously. For
example, THO complex 4, a context-dependent transcriptional activator in the T-cell receptor alpha
enhancer complex, showed highest expression at middle stage of adipogenesis while SNF2 alpha, a
chromatin remodeling protein, was downregulated upon initiation of adipogenesis and remained so
during subsequent time points. This study using a 5-plex SILAC to investigate dynamics illustrates
the power of this approach to identify differentially expressed proteins in a temporal fashion.
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Introduction
The adipose compartment houses the largest energy reserves of the body in humans in the form
of triacylglycerols and plays an essential role in maintaining the energy balance1. It is now
well recognized that adipogenesis can occur throughout the lifetime of humans and the capacity
to increase the adipocyte number is retained in adulthood2. Thus, identification of key players
in the process of adipogenesis is important especially in regard to manipulating them for
therapeutic purposes. Over the last several years, adipocytes have also been shown to possess
regulatory functions in processes such as satiety and reproduction through the secretion of a
variety of hormones, cytokines, growth factors and other bioactive substances, conceptualized
as adipocytokines3. These include adiponectin, leptin, plasminogen activated inhibitor 1
(PAI-1), and other secreted factors4. Another important class of proteins that play a vital role
in adipogenesis is transcription factors such as peroxisome proliferator activated receptor-γ5,
6 and the CCAAT-enhancer binding protein-α7, which have been characterized in detail during
adipocyte differentiation. Thus, we sought to identify additional molecules involved in
adipogenesis by analyzing nuclear and secreted compartments during the differentiation of
adipocytes.
Cell lines and primary cultures are useful cell models for elucidation of molecular and
developmental pathways leading to adipogenesis. 3T3-L1 preadipocytes are one of the
commonly used model systems for studying the process of adipocyte differentiation. DNA
microarray studies have been carried out to investigate specific cellular programs in the
regulation of gene expression during differentiation of 3T3-L1 preadipocytes8. They found
that that expression levels of 1259 transcripts changed 3-fold or more during differentiation of
3T3-L1 preadipocytes to adipocyte. In a similar study, Burton et al.9 reported 636 transcripts
to be upregulated at least 2 fold and 380 transcripts downregulated in adipocytes as compared
to preadipocytes. However, since adipogenesis is a dynamic and actively regulated process, a
temporal analysis of differential protein expression during adipogenesis would be crucial for
understanding adipocyte biology. We have previously identified factors that are secreted by
adipocytes using liquid chromatography tandem mass spectrometry (LC-MS/MS)10. In that
study, which was not designed to be quantitative, the differential expression of a small subset
of molecules was confirmed by RT-PCR and Northern blot analysis. More recently, using 1D
gel based LC-MS/MS, another non-quantitative proteomic analysis was reported in which
various subcellular fractions from adipocytes were characterized11.
Thus far, there is no study describing a quantitative analysis of the dynamics of the adipocyte
proteome during differentiation. Stable isotope labeling with amino acids in cell culture
(SILAC) is a simple and robust in vivo labeling method that can be applied to studies analyzing
cells at multiple time points such as during cellular differentiation. Traditionally, SILAC has
been used for analyzing two or three different states. Here, we describe the development and
application of a five-plex SILAC experiment using four different heavy stable isotopic forms
of arginine for the analysis of nuclear and secreted proteins of adipocytes at 5 different time
points during adipogenesis. We identified 882 nuclear/secreted proteins using SILAC labeling
followed by 2D-LC-MS/MS. Almost half of the identified proteins from each compartment
could be quantitated enabling the identification of potential regulators and markers at different
states of adipocyte differentiation.
Experimental Section
Cell culture and SILAC labeling
Custom Dulbecco's modified Eagle's medium (DMEM) without arginine was purchased from
Invitrogen (Carlsbad, CA). arginine-13C4, arginine-13C6, arginine-13C615N4, and
arginine-13C615N42H7 were purchased from Cambridge Isotope Laboratories (Andover, MA).
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A detailed protocol for SILAC media preparation can be found at http://www.silac.org. 3T3-
L1 preadipocytes were grown in normal DMEM media (light) and 4 different custom DMEM
media supplemented with above 4 different isotopic forms of arginine (heavy) along with 10%
calf serum. The cells from each condition were cultured through at least five passages until the
complete incorporation of heavy arginine. 3T3-L1 cells were differentiated essentially as
described previously10. Two days after the cells reached confluence (Day 0), they were
induced to differentiate by changing the medium to corresponding medium supplemented with
10% fetal bovine serum, 0.5 mM 3-isobutyl-1-methyxanthine (Sigma, St. Louis, MO), 1 µM
dexamethasone (Sigma), and 167 nM insulin (sigma). At the end of Day 2, the medium was
replaced with DMEM supplemented with 10% fetal bovine serum and 167 nM insulin. At the
end of Day 4, insulin was withdrawn, and the cells were continued to grow in corresponding
media until the end of Day 7. The cells grown in light arginine, arginine-13C4, arginine-13C6,
arginine-13C615N4, and arginine-13C615N42H7 media were subjected to 18 hours serum
starvation in corresponding serum free media at the end of Day 0, Day 1, Day 3, Day 5 and
Day 7, respectively. After the collection of supernatant, the corresponding cells were washed
3 times in ice cold PBS and stored at −80°C until the preparation of subcellular fractions.
Preparation of protein samples
For secretome analysis, the supernatant collected from each state was combined and
concentrated using a 3,000 Da cutoff Centriprep spin column (Millipore, Billerica, MA). The
preparation of nuclear fraction was performed as described previously12. Briefly, the harvested
cell pellets from each state were mixed equally according to protein concentration, which was
measured using an aliquot from each sample. The cell preparations were resuspended in
hypotonic lysis buffer (20mM Tris-Cl, pH 7.5; 10mM NaCl; 3 mM MgCl; 1mM DTT; 1mM
sodium orthovanadate; 10mM β-glycerol phosphate) with protease inhibitor cocktail (Roche
Diagnostic, Mannheim, Germany) and lysed in Dounce homogenizer with 20 strokes. The
lysates were then centrifuged at 1,000g for 10 minutes at 4 °C. The nuclear extract pellet was
redissolved in 6 M urea before reversed phase protein fractionation.
Oil red O staining
Oil red O staining was performed to monitor progression of adipocyte differentiation as
described previously1. Briefly, cells on Day 0, Day 1, Day 3, Day 5 and Day 7 were washed
three times with PBS and then fixed by 3.7% formaldehyde for 2 minutes. Oil red O (0.5%)
was prepared in isopropanol, mixed with water at 3:2 ratio and filtered through a 0.45 µm filter.
The fixed cells were incubated with Oil red O reagent for one hour at room temperature and
then washed with water. The stained fat droplets in the cells were visualized by light
microscopy and photographed.
Reversed phase protein fractionation and tryptic digestion
Cell free protein lysates and secreted proteins were reduced and alkylated in denaturing
conditions. Protein samples were adjusted to a volume of 0.3 ml followed by addition of solid
urea to a final concentration of 6M. The sample was reduced with 50 µl of 50 mM dithiothreitol
at 60°C for 20 minutes and alkylated by adding 50µl of 100mM iodoacetamide for 30 minutes
at room temperature in the dark. The sample (500µl) was acidified using TFA (1%) and injected
onto a 4.6mm × 50mm Hi Recovery Protein mRP-C18 column (Agilent, Santa Clara,
California) using an external sample injection loop. Intact proteins was eluted using a gradient
increasing from 97% buffer A (0.1% TFA) / 3% buffer B (0.08% TFA in acetonitrile) to 40%
Buffer A / 60% buffer B in 36 minutes. The gradient was delivered by an Agilent 1100 series
HPLC system at a flow rate of 800 µl/minute. Eluted proteins were detected by UV (280 nm)
and fractions were collected every 30 seconds. Protein fractions were lyophilized completely
to dryness and redissolved in 25 µl of 100mM ammonium bicarbonate containing trypsin of
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concentration (40 to 110 ng) proportional to the UV signal for the given fraction (data not
shown). The ratio between trypsin and substrate was kept approximately constant at 1:50.
Digested fractions were lyophilized and stored at −80°C until LC-MS/MS analysis.
LC-MS/MS and Data analysis
The digested peptides were reconstituted in 5 µl of 0.1% formic acid and analyzed using
reversed phase liquid chromatography coupled to QSTAR Pulsar mass spectrometer (Applied
Biosystems). Liquid chromatography was set up on an Agilent 1100 series, to allow sample
cleanup using trap column (75 µm × 3 cm, C18 material 5-10µm, 120Å, YMC, Japan) and
peptide fractionation on an analytical column (75 µm × 10 cm, C18 material 5µm, 120Å, YMC,
Japan). API electrospray was carried out with the help of an emitter tip 8 µM (New Objective,
Woburn, MA). The peptides were eluted using a gradient of solvent A (0.1% formic acid, 3%
acetonitrile) and solvent B (90% acetonitrile, 0.1% formic acid). Solvent gradient from 5 to 10
% solvent B was used for sample cleanup on trap column followed by a gradient of 10 to 40%
of solvent B for peptide fractionation over analytical column. MS spectra were acquired in a
survey scan (m/z range from 350 to 1200) in a data dependent mode selecting three most
abundant ions for MS/MS. An exclusion time of 45 seconds were used. LCMS/MS data was
acquired using Analyst QS 1.1 (MDS Sciex, Concord, Ontario, Canada) and mascot generic
format (mgf) files were generated from instrument raw (*.wiff) files using the mascot.dll data
import filter script in Mascot Daemon (version 2.2.2) (Matrixscience, Manchester, UK).
Mascot Daemon merged data for nuclear and secretome fractions were searched in Mascot
v2.2.0 (Matrixscience, Manchester, UK) search engine using mouse RefSeq database version
26 and search results were saved in Internet Explorer 6.0. Reverse database version RefSeq26r
was searched to estimate the false discovery rate. The following variable modifications were
used in Mascot for searching the database; arginine-13C4, arginine-13C6, arginine-13C615N2,
arginine-13C615N22H7 and oxidation of methionine. Carbamidomethylation of cysteine
residues was used as a fixed modification. The mass tolerance was set 0.3 atomic mass units
for precursor and 0.3 atomic mass units for fragmented ions. Relative quantitation of stable
isotope labeled peptides was performed using MSQuant v1.4.3a39 downloaded from
http://msquant.sourceforge.net. The “new_MSQ_quantitationModes.xml” file was modified
to include base mass differences for heavy arginines and Mascot output matching string in
order to MSQuant associate Mascot search results with instrument raw files. MSQuant
quantitates individual peptide ratios at different time points at chromatographic peaks and
calculates protein ratios with standard deviation. Mascot search results in .html format were
parsed with the raw data file in MSQuant. Quantitative as well as qualitative data were manually
inspected using MSQuant. Data from the MSQuant analyses were imported via a CSV format
to ProteinCenter 1.2 (Proxeon A/S, Odense, Denmark) for a bioinformatics statistical analysis.
Western Blot Analysis
Western blot analysis was carried out for a subset of differentially expressed proteins. Briefly,
nuclear and secreted samples from Day 0, Day 1, Day 3, Day 5 and Day 7 of adipocyte
differentiation were resolved by SDS-PAGE and transferred onto a nitrocellulose membrane
(Protran, Whatman). The membranes were blocked using 3% nonfat dry milk in phosphate-
buffered saline with 0.1% Tween 20 (PBS-T) for 1 hour at room temperature. After incubating
the membranes with primary antibody, the bound primary antibody was detected using HRP-
conjugated secondary antibody with an enhanced chemiluminescence kit (Amersham
Biosciences, Piscataway, NJ). Following antibodies with appropriate dilution were used in this
study: Poly(A)-binding protein 1 (1:1000, Cell Signaling Technology, Cat No. 4992), Splicing
factor, arginine/serine rich 2 (1:200, Santa Cruz, Cat No. SC-10254), Lumican (0.2µg/ml, R&D
Systems, Cat No. AF2846), and Annexin V (1:500, Santa Cruz, Cat No. SC-32321).
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Results and Discussion
Quantitative proteomic data
Thus far, SILAC has been most commonly used for studying 2 or 3 different states
simultaneously using different isotopic forms of arginine and lysine13. Although it has been
shown that two 3-plex SILAC experiments can be used to monitor 5 different states, it requires
two different experiments carried out in parallel14. We have developed a 5-plex SILAC
labeling strategy using five different isotopic versions of arginine to simultaneously monitor
proteins derived from five different samples. This method was used to study adipocyte
differentiation at five time points (Day 0, Day 1, Day 3, Day 5 and Day 7) during 7-days
differentiation of pre-adipocytes to adipocytes as shown in Figure 1A. By Oil red O staining,
gradual morphological changes of adipocytes during adipogenesis can be seen clearly, which
were demonstrated by gradually increased fat droplets observed in the cells in this study (Figure
1B). To address the molecular alterations responsible for the adipogenic process, we took a
global proteomics approach targeting two important biological compartments of the
differentiating adipocytes: nuclear proteins and secreted proteins (secretome).
Our major analytical concern regarding our choice of labeled amino acids was that the
deuterium labeled arginine (Arginine-13C615N4N2H7), being 17 Da heavier than normal
arginine, would give rise to a chromatographic shift15. It has also been reported that grouping
deuterium next to polar groups can greatly minimize the observed shift, which is consistent
with solvophobic theory16. The seven deuterium atoms used in the 17 Da heavier arginine are
positioned in the aliphatic chain and on the secondary nitrogen and all deuterium atoms are
therefore not in close proximity to the polar amine moiety. We investigated a number of peptide
elution profiles to see if any chromatographic shift for the deuterium labeled peptides was
observed. The elution profiles for 6 peptide sets are shown in Figure 2. The upper panel of each
figure shows the measured MS spectrum for the peptide set, while the lower panels show the
corresponding elution profiles for each of the five isotopic peptides indicating that these five
isotopically distinct peptides indeed co-eluted in LC-MS/MS analysis. Regarding peptides
labeled with 13C and 15N; we and others17-19 have previously shown that the use of these
isotopes does not cause any critical elution differences for peptides.
In the present study, a total of 882 proteins were identified using LC-MS/MS analysis. Of these,
581 were identified in the fraction that had been enriched for the nuclear fraction while the
remaining 301 originated from the fraction defined as the secretome. From each fraction,
almost half of the proteins (nucleus: 280 proteins (48%) and secretome: 147 proteins (49%))
were identified with one or more arginine containing peptides, which allowed quantitation.
Fold change values of proteins from Day 1 until Day 7 were calculated using Day 0 as a
reference. A Gene Ontology cellular component analysis revealed that approximately half
(284) of the proteins found in the nuclear fraction were previously known nuclear proteins as
shown in Figure 3A. A similar analysis of the proteins identified in the secretome revealed that
53% (149) were either membrane bound or could be classified as being secreted proteins as
shown in Figure 3B.
Differentially expressed proteins in the nuclear proteome
Using a 2-fold change as a cut-off to designate up or downregulated proteins, 23 proteins
showed alterations on Day 1. However, at least 150 proteins showed more than 2-fold change
at each time point from Day 3 to Day 7 as shown in Table 1. These observations indicate that
significant morphological and biological changes occurred during middle or late stage of
adipogenesis. Among the 280 proteins quantitated from nuclear fraction, 144 proteins showed
consistently increased expression at least at 3 time points.
Molina et al. Page 5
J Proteome Res. Author manuscript; available in PMC 2010 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Upregulated proteins—A heat map demonstrating the dynamics of protein expression in
the nuclear fraction is shown in Figure 4. There are two major expression patterns observed in
upregulated proteins: one pattern includes proteins that exhibited maximum expression on Day
3. These are represented by small nuclear ribonucleoprotein D1, PHD-finger 5A and THO
complex 4. Small nuclear ribonucleoprotein D1 has been shown to provide T cell help to
produce anti-dsDNA antibodies involved in lupus development20. PHD-finger 5A protein
belongs to a novel murine multigene family that is highly conserved during evolution. The
function of PHD-finger 5A is not clear but it may act as a chromatin-associated protein21 THO
complex 4, also known as ALY, mediates context-dependent transcriptional activation by
facilitating the functional collaboration of multiple proteins in the T-cell receptor alpha
enhancer complex22. Thus, these proteins may participate in transcriptional regulation in the
early or middle stage of adipocyte differentiation. The other expression pattern includes
proteins that showed a gradual increase in levels from Day 3 to Day 7, and are exemplified by
lipoprotein lipase, isocitrate dehydrogenase 1 (NADP+) and EH-domain containing 2 proteins.
Lipoprotein lipase is a key enzyme in energy metabolism, catabolizing triglycerides into free
fatty acids and glycerol23. It is well known as an adipocyte specific gene and significantly
induced in differentiated adipocytes8, 24. In the present study, lipoprotein lipase remained
unchanged on Day 1, started to increase on Day 3 and reached peak expression on Day 7, which
is consistent with previous observations. The isocitrate dehydrogenase 1 (NADP+) catalyzes
oxidative decarboxylation of isocitrate to α-ketoglutarate and require NADP+ to produce
NADPH, which plays an antioxidant role during oxidative stress25. Proteins that have an EH
domain can carry out a variety of cellular functions ranging from regulation of the actin
cytoskeleton, signal transduction and transcriptional regulation to control of the endocytic
pathway. Mammalian cells express four highly homologous C-terminal EH-domain-
containing paralogs (EHD1-EHD4), which are significantly similar in sequence26. High
expression of EH-domain containing 2 impairs endocytosis of GLUT4 in cultured adipocytes
and transferrin in COS cells27. The isocitrate dehydrogenase 1 (NADP+) and EH-domain
containing 2 showed similar expression pattern with lipoprotein lipase, which indicates that
both proteins might be novel potential markers of adipogenesis.
Downregulated proteins—In the nuclear faction, SNF2 alpha was downregulated at all
stages (Days 1 through 7) as compared to preadipocytes (Day 0). SNF2 alpha, also designated
BRM, belongs to SWI/SNF family, a chromatin remodeling complex and regulates the
expression of several transcription factors in an ATP-dependent manner. It was found that its
expression gradually increased during the differentiation of liver cells28. The process of
adipocyte differentiation forced by overexpression of adipogenic regulatory proteins was
inhibited upon expression of dominant-negative hBRM in several adipocytes29. However, we
observed downregulation of SNF2 alpha from Day 1 to Day 7 during adipogenesis in the present
study. One explanation for the discrepancy could be that the dominant negative does not fully
abrogate the physiologic functions of SNF2 alpha in adipocytes. In this respect, the effect of
SNF2 alpha deletion on adipogenesis could help explain these seemingly disparate findings.
Another reason could be that we used a different inducer for driving adipocyte differentiation
and that the dominant negative SNF2 alpha only inhibits when PPAR gamma activation directly
drives adipocyte differentiation. In any case, our findings suggest that additional
experimentation is required to understand this process in detail.
Differentially expressed proteins in the adipocyte secretome
The proteins secreted by adipocytes exert crucial roles in the energy homeostasis and other
procedures in a paracrine or endocrine manner. Thus, we also examined the dynamics of
expression of proteins secreted by adipocyte during adipogenesis. A total of 147 proteins were
quantitated in the secretome of adipocytes from this experiment. It was found that most of the
quantitated proteins showed a very low level on Day 1 (Table 2). This coincides with the
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observation that the media on that particular day has a much higher viscosity, than observed
on Day 0, Day 3, Day 5 and Day 7. It is believe that this greater viscosity is due to an increased
secretion of Glycans. Even though the majority of proteins showed decreased expression on
Day 1, there are still 6 proteins increased more than 2-fold. As shown in Table 2, abundance
of more than 40 proteins changed at each time point from Day 3 to Day 7. A heat map shows
the secreted proteins that were quantitated in this experiment (Figure 5).
Upregulated proteins—A subset of secreted proteins demonstrated highest expression at
the Day 3 time point, which is exemplified by Biglycan, Nidogen 1 and Nidogen 2. Biglycan
is one of small chondroitin sulfate proteoglycans, which comprise a subset of virtually
ubiquitous extracellular proteoglycans in most connective tissue matrices30. Depletion of
biglycan affected the differentiation of tendon stem/progenitor cells by modulating bone
morphogenetic protein signaling31. Nieden et al. presented that Biglycan can drive embryonic
stem cells to the cartilage, osteoblast or adipogenic fates depending on the supplementary co-
factors32. In the present study, Biglycan protein existed in all stages during adipogenesis and
presented a peak expression on Day 3. Considering the function of Biglycan in stem cell
differentiation, our results indicate that the secreted Biglycan may assist in the differentiation
of proadipocytes from Day 3 to Day 5 of maturation. Nidogen 1 and 2 are basement membrane
glycoproteins and previous biochemical and functional studies indicate that they may play a
crucial role in basement membrane assembly. Bader et al. found that deficiency of both
nidogens in mice resulted in perinatal lethality. Nidogen 1 and 2 do not appear to be crucial in
establishing tissue architecture during organ development; instead, they are essential for lung
development and for maintenance and/or integrity of cardiac tissue33. The expression of
Nidogen1 and 2 during adipogenesis showed a similar pattern: both of them had marginal
expression at early and late stage of adipocyte differentiation. However, they showed the
highest expression half way through the differentiation (Day 3). Thus, like Biglycan, Nidogen
1 and 2 might be involved in the middle stage of adipocyte differentiation.
Another subset of proteins showing consistently increased expression at both Day 5 and Day
7 compared with Day 0 to Day 3, such as Acrp 30. Acrp30, also called adiponectin, is encoded
by adipocyte-specific apM-1 gene and specifically secreted by adipocytes. Preadipocytes with
overexpressed acrp30 were observed to differentiate into adipocytes more rapidly34. ApM-1-
mRNA and Acrp30 proteins were found to be upregulated from Day 4 to Day 9 during the
adipocyte differentiation as shown by RNase protection assay and Western blot analysis35.
Our data also showed robust expression of Acrp30 in the secretome from Day 3 to Day 7 of
adipogenesis using MS analysis. Noticeably, our previous study also demonstrated that Acrp30
was highly secreted by adipocyte compared to preadipocytes10. Our data highlights that
targeting adiponectin becomes promising strategy in the treatment of obesity related diseases.
Downregulated proteins—There are 17 proteins in secreted fraction exhibiting a
consistently reduced expression during adipogenesis. Interestingly, three isoforms of
tropomyosins were observed among those proteins. Tropomyosins are encoded by 4 different
genes, which produce over 40 isoforms through alternative splicing36. Particular tropomyosin
isoforms have been observed to be associated with cellular actin-based processes including the
contractile ring, cortical actin, stress fibres, lamellipodial actin networks and filopodia36. The
spatial and temporal regulation of tropomyosin isoforms are involved in the establishment of
microfilaments in various tissues and cells. Thus, tropomyosin family is a predominant
regulator in actin filament dynamics, which need to be tightly regulated in proliferation,
apoptosis, differentiation and other cellular processes37. The expression of tropomyosin 1, 3
and 4 were decreased from Day 1 to Day 7 during adipocyte differentiation in our MS analysis,
which indicates the tropomyosin family may be also an important player in adipogenesis.
Another example for decreased proteins in secreted fraction is zyxin. Zyxin is a component of
adhesion plaques that has been suggested to perform regulatory functions at those specialized
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regions of the plasma membrane. Zyxin was found to be significantly upregulated in melanoma
cells compared to melanocytes and its expression directly related to cell spreading and
proliferation and inversely related to differentiation38. Here, zyxin was demonstrated to
decrease during adipogenesis, which may also imply that secreted zyxin is inversely related to
adipocyte differentiation.
Western blot analysis for differentially expressed proteins
In order to validate the results from SILAC-based proteomic analysis, Western blot analysis
was carried out for four representative proteins. The Western blot results and corresponding
mass spectrum for each protein are displayed in Figure 6. Poly(A)-binding protein 1, Splicing
factor, arginine/serine-rich 2 and Lumican showed a similar expression pattern in that they
were expressed at low levels on Day 0 and Day 1, but there were significantly increased on
Day 3 followed by a decrease on Days 5 and 7. As shown in Figure 6, the Western blot results
for these three molecules closely correlate with the SILAC data. In contrast, the Western blot
analysis of Annexin V does not correlate with the quantitative mass spectrometry data. The
SILAC data indicates that Annexin V shows the highest expression on Day 7 as compared to
the other times. However, the Western blot shows that it has a higher expression on Days 3
and 5 than on Day 7. We think that this apparent discrepancy between MS and Western blot
analysis is likely due to the non-specificity of the antibody against Annexin V. It must be noted
here that a significant fraction of differentially expressed proteins that we have identified do
not have any commercially available antibodies against them illustrating the power of
quantitative proteomic approaches. In these cases, if additional validation is still required,
AQUA type of studies (either in an MRM type of experiment or non-MRM type of experiment)
can be carried out.
Conclusions
Until recently, profiling of dynamics of proteins in multiple biological conditions was limited
by lack of accurate quantitative techniques. Stable isotope labeling based quantitative
proteomic profiling technology has become popular mass spectrometry analysis for such
analysis. Although, recent development of in vitro labeling methods such as iTRAQ reagents
allows simultaneous proteomics comparison of up to 8 different samples, the drawbacks of
these methods include biases due to labeling efficiency and limited fractionation options at
protein and subcellular levels. Thus, in vivo labeling using the SILAC method can be used in
the case of cell cultures to overcome these limitations. In this study, we were able to extend
the SILAC labeling method to use up to 5 different states for a simultaneous comparison of
protein abundance. We have successfully identified many differentially expressed proteins
during adipogenesis, which may be of importance for this process. Further validation studies
are necessary to evaluate the large number of proteins identified in differentiating adipocytes
and their secretome. One of the technical disadvantages of SILAC five state experiments is
limited number of amino acids, which can be made use for differential isotope labeling. Hence,
use of arginine alone in this study resulted in lack of quantitation of some proteins identified
in this study. Further, blocking the lysine groups and use arginine specific enzymes may
increase the efficiency of this arginine based 5-state SILAC approach. Overall, this study
illustrates the potential applications of this method to study spatiotemporal dynamics of a
number of biological processes in cell culture-based systems.
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Figure 1. 5-plex SILAC strategy and Oil red O staining for adipocyte differentiation
A) Preadipocytes were grown in different cell culture media containing 5 different isotopic
forms of arginine as shown until complete isotopic amino acid incorporation. After the
induction of differentiation, cells were harvested on Day 0, Day 1, Day 3, Day 5 and Day 7 of
the differentiation process and combined after protein normalization. In parallel, serum free
media from five different cell populations were collected at the indicated time points and
combined. The nuclear fraction and the secretome were processed and analyzed by LC-MS/
MS. B) Differentiation of adipocytes was confirmed by Oil red O staining. Cells on Day 3,
Day 5 and Day 7 show a progressive increase in red staining for fat droplets, indicating the
extent of adipocyte differentiation.
Molina et al. Page 12
J Proteome Res. Author manuscript; available in PMC 2010 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2. Mass spectra and elution profiles for SILAC labeled peptide sets
Upper panels show the mass spectra and lower panels show elution profiles. The color code
of the peptide elution profiles are: red: Day 0, blue: Day 1, green: Day 3, violet: Day 5 and
black: Day 7, represented by the isotopes: normal, 13C4, 13C6, 13C615N4, and 13C615N42H7,
respectively. The mass differences between the isotopic labeled peptides are shown in each
upper panel. The sequence and charge states of the depicted peptides are as following. Figure
2 A: The peptides from secreted fraction. A: APILIATDVASR, doubly charged (DEAD box
polypeptide 5), B: LGVEFDEITADDRK, triply charged (Fatty acid binding protein 2) and C:
WISIMTER, doubly charged (Annexin A2). Figure 2 B: the peptides from nuclear fraction. A:
IETIEVMEDR, doubly charged (similar to heterogeneous nuclear ribonucleoprotein A3
isoform 7), B: AAAITSDLLESLGR, doubly charged (osteoblast specific factor 2, fasciclin I-
like), C: FGVEQDVDMVFASFIR, triply charged (pyruvate kinase 3).
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Figure 3. Gene Ontology and cellular component analysis
Gene Ontology analysis for identified nuclear and secreted proteins was performed using
ProteinCenter version 1.2 (Proxeon A/S, Odense, Denmark). Panel A shows the analysis for
the 581 proteins identified in the nuclear enriched fraction, while panel B shows the
corresponding analysis for the proteins identified from the secretome. Approximately half
(284) of the proteins found in the nuclear fraction were previously known nuclear proteins. For
the secreted proteins, the analysis revealed 149 proteins were membrane or cell surface
proteins.
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Figure 4. Heat map of quantitated nuclear proteins
The heat map shows the temporal profile of each protein identified and quantitated in nuclear
fraction by 5-plex SILAC based MS analysis. Relative expression abundance for each protein
is indicated in each frame using Day 0 as a reference. For reference, a color intensity scale is
included in the right side.
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Figure 5. Heat map of quantitated secreted proteins
The heat map shows the temporal profile of each protein identified and quantitated in the
secretome by 5-plex SILAC based MS analysis. Relative expression abundance for each
protein is indicated in each frame using Day 0 as a reference. For reference, a color intensity
scale is included in the right side.
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Figure 6. Western blot analysis for a subset of differentially expressed proteins
The left panel shows Western blot results with the right panel showing MS/MS spectra of a
peptide from the corresponding protein.
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Table 1
Distribution of nuclear proteins showing altered expression during adipogenesis
Fold-change Day 1 Day 3 Day 5 Day 7
> 2 12 249 153 204
<0.5 11 2 2 2
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Table 2
Distribution of secreted proteins showing altered expression during adipogenesis
Fold-change Day 1 Day 3 Day 5 Day 7
> 2 6 50 41 57
<0.5 111 21 23 37
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